ID

14319

Descrizione

Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00003910

collegamento

https://clinicaltrials.gov/show/NCT00003910

Keywords

versioni (1)
  1. 10/04/16 10/04/16 -
Caricato su

10 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Leukemia NCT00003910

Inglese

Eligibility Leukemia NCT00003910

1 moduli  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003910
Criteria
Descrizione

Criteria

phenotypic studies from peripheral blood showing cd3+, cd57+ cells greater than 400/mm3 or cd8+ cells greater than 650/mm3 within eight weeks prior to registration
Descrizione

Cd3+, cd57+, cd8+ cells

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1267816
UMLS CUI [2]
C0054965
UMLS CUI [3]
C0085358
evidence for clonal t-cell receptor gene rearrangement within one year prior to registration
Descrizione

Clonal t-cell receptor gene rearrangement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1516680
at least one of the following: severe neutropenia less than 500/mm3, neutropenia associated with recurrent infections, symptomatic anemia, or transfusion-dependent anemia
Descrizione

Neutrophile count, recurrent infections, anemia or transfusion-dependent anemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0200633
UMLS CUI [2]
C0239998
UMLS CUI [3]
C0002871
UMLS CUI [4]
C3666003
bilirubin ≤ 2.0 mg/dl, sgot(ast) ≤ 1.5 times normal, and creatinine ≤ 2.0 mg/dl within 4 weeks prior to registration
Descrizione

bilirubin, ast and creatinine measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201975
ecog performance status of 0-2
Descrizione

Ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
at least 18 years of age
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent
Descrizione

Written informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
exclusion:
Descrizione

Exclusion criteria

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0680251
prior therapy with oral mtx or oral cy
Descrizione

Oral mtx or oral cy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3238745
UMLS CUI [2]
C1271102
previous or concurrent malignancies except inactive non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer if the patient has been disease free for over 5 years
Descrizione

Further malignancies

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C2216722
UMLS CUI [3,1]
C0006826
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C0242793
pregnant or breast-feeding for female patients
Descrizione

Gynaecological status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious medical illness, other than that treated by the study, which would limit survival to less than 2 years, or psychiatric condition which would prevent informed consent
Descrizione

Comorbidity and informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0023671
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0439801
UMLS CUI [2,3]
C0004936
note: to be eligible for step 2 of this study, patients were required to have no response after at least 4 months of methotrexate treatment.
Descrizione

Disease response

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1704632
Ritorna all'inizio della pagina

Similar models

Eligibility Leukemia NCT00003910

1 moduli
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00003910
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Cd3+, cd57+, cd8+ cells
Item
phenotypic studies from peripheral blood showing cd3+, cd57+ cells greater than 400/mm3 or cd8+ cells greater than 650/mm3 within eight weeks prior to registration
boolean
C1267816 (UMLS CUI [1])
C0054965 (UMLS CUI [2])
C0085358 (UMLS CUI [3])
Clonal t-cell receptor gene rearrangement
Item
evidence for clonal t-cell receptor gene rearrangement within one year prior to registration
boolean
C1516680 (UMLS CUI [1])
Neutrophile count, recurrent infections, anemia or transfusion-dependent anemia
Item
at least one of the following: severe neutropenia less than 500/mm3, neutropenia associated with recurrent infections, symptomatic anemia, or transfusion-dependent anemia
boolean
C0200633 (UMLS CUI [1])
C0239998 (UMLS CUI [2])
C0002871 (UMLS CUI [3])
C3666003 (UMLS CUI [4])
bilirubin, ast and creatinine measurement
Item
bilirubin ≤ 2.0 mg/dl, sgot(ast) ≤ 1.5 times normal, and creatinine ≤ 2.0 mg/dl within 4 weeks prior to registration
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201975 (UMLS CUI [3])
Ecog performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion criteria
Item
exclusion:
boolean
C0680251 (UMLS CUI [1])
Oral mtx or oral cy
Item
prior therapy with oral mtx or oral cy
boolean
C3238745 (UMLS CUI [1])
C1271102 (UMLS CUI [2])
Further malignancies
Item
previous or concurrent malignancies except inactive non-melanoma skin cancer, in situ carcinoma of the cervix, or other cancer if the patient has been disease free for over 5 years
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
C0006826 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0242793 (UMLS CUI [3,3])
Gynaecological status
Item
pregnant or breast-feeding for female patients
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Comorbidity and informed consent
Item
serious medical illness, other than that treated by the study, which would limit survival to less than 2 years, or psychiatric condition which would prevent informed consent
boolean
C0023671 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
C0004936 (UMLS CUI [2,3])
Disease response
Item
note: to be eligible for step 2 of this study, patients were required to have no response after at least 4 months of methotrexate treatment.
boolean
C1704632 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial